Globus Medical Inc Class A (GMED)

Industry Medical Devices


This stock can be held in an Investment ISA and an Investment Account
Sell

$85.65

Buy

$89.00

arrow-down$-2.18 (-2.45%)

Prices updated at 13 Dec 2025, 00:55 EST
| Prices minimum 15 mins delay
|
Prices in USD

Globus Medical Inc is a medical device company. It operates under two divisions that include innovative fusion and disruptive technology developing products for patients with musculoskeletal disorders for various treatment.

Income statement

20232024
1,568m2,519m
1,020m1,484m
202m220m
12.878.72
123m103m
347m474m
Sales, General and administrative643m981m
Interest expenses--
Provision for income taxes43m18m
Operating expenses818m1,264m
Income before taxes165m121m
Net income available to common shareholders123m103m
1.090.76
Net interest income20m-4m
Advertising and promotion--
Net investment income, net--
Realised capital gains (losses), net--
Total benefits, claims and expenses--
Earnings per share (diluted)1.070.75
Free cash flow per share1.1942.1592
Book value/share30.713129.6128
Debt equity ratio0.1271740.02001

Balance sheet

20232024
Current assets1,915m2,177m
Current liabilities392m856m
Total capital4,415m4,177m
Total debt520m537m
Total equity3,998m4,177m
Total non current liabilities--
Loans417m-
Total assets5,086m5,252m
Total liabilities--
Cash and cash equivalents467m784m
Common stock136m137m

Cash flow

20232024
Cash at beginning of period150m467m
Cash dividends paid--
165m405m
Investments (gains) losses303m-176m
467m784m
Net income--
243m521m
-78m-115m
The figures shown in the tables are quoted in the currency of the stock selected.
Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.


Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.